OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Clinical Pharmacology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Issue Highlights	81
	65
Issue Information	57
	57
Pharmacokinetics of the inactive favipiravir metabolite, favipiravir hydroxide (M1), as a proxy for establishing metabolic activity in patients receiving intravenous favipiravir for treatment of SARS‐	56
Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales	49
Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food	48
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population	46
Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’	45
Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection	44
Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pre	43
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials	42
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin	41
Letter to the editor of the Brit J Clin Pharmacol on Hartjes et al. 2025 https://doi.org/10.1002/bcp.70176	39
Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients	38
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data	37
Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial	36
Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery	36
Modelling the progression of illicit substance use patterns from real‐world evidence	36
Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination	36
Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study	35
Neck‐vein thrombosis during spaceflight	33
Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model	32
Effect of oral clonidine on pain reduction in patients with opioid use disorder in the emergency department: A randomized clinical trial	31
Selected Abstracts from Pharmacology 2024	31

Pharmacogenetic CYP2B6 variants affect steroid hormone metabolism in human breast cancer cells	30
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database	29
A first‐in‐human study of the anti‐inflammatory profibrinolytic TMS‐007, an SMTP family triprenyl phenol	29
Superiority of ceftazidime off‐label high‐dose regimen in PK/PD target attainment during treatment of extensively drug‐resistant Pseudomonas aeruginosa infections in cancer patients	28
Infusion rate adjustment in enzyme replacement therapy with pabinafusp alfa for mucopolysaccharidosis II	28
Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?	28
Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study	28
Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss	28
Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects	28
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing	28
PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4 ⁺ lymphocytes	28